• Home
  • About Domain Associates
    • History
    • Investment Strategy
  • Team
  • Portfolio
  • News
  • Contact
  • Connect
  • Privacy Policy
  • Site Map
• Milestone Pharmaceuticals Provides Positive Regulatory Updates for Etripamil Pivotal Program in PSVT
• Antios Therapeutics Doses First Patients in SAVE 1, a Phase 2a Study of ATI-2173 in Patients with Ch
• Fractyl Health Publishes Two-Year Durability Data After a Single Revita DMR® Therapeutic Procedure i